Filing Details
- Accession Number:
- 0001382963-15-000070
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-25 21:03:22
- Reporting Period:
- 2015-06-24
- Filing Date:
- 2015-06-25
- Accepted Time:
- 2015-06-25 21:03:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1460702 | Ritter Pharmaceuticals Inc | RTTR | Pharmaceutical Preparations (2834) | 263474527 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1631673 | Noah Doyle | Ritter Pharmaceuticals, Inc. 1801 Century Park East, #1820 Los Angeles, CA 90067 | Yes | No | No | No |
Transaction Summary
Purchased: | 800,000 shares | Avg. Price: $5.00 | Total Value: $4,000,000.00 |
Number of Shares After Transactions: | 800,000 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-24 | 800,000 | $5.00 | 800,000 | No | 4 | P | Indirect | by Javelin Venture Partners, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | by Javelin Venture Partners, L.P. |
Footnotes
- As the managing director of Javelin Venture Partners, L.P. the reporting person may be deemed the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.